Thu, Oct 23, 2014, 1:00 PM EDT - U.S. Markets close in 3 hrs.


% | $
Quotes you view appear here for quick access.

Fibrocell Science, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dmesshian dmesshian Oct 7, 2011 3:47 PM Flag


    Dude, I have MUCH respect for the "socially responsible" hard working folks at Allergan who seem to get it right in all of their "mass market advertising".

    Please scroll down to the bottom of this latest add and see what "GREAT and Responsible Companies, like Allergan, do to inform the customer/patients -- the WORLD -- of risks associated with their products.

    There is not an iota of a hint of "under-the-table" PAYOLA to any blogging entities nor shady stuff, pal.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If you were anymore transparent, you'd be invisible.

      Im sorry Laviv is going to put you out of business but thats the way it goes sometimes, pal.

    • SPLIFF/DMesshian/Lebutre: You just dug your own grave here pal by admitting you are affiliated with Alergan: Read on. Hopefully within the next year, you will see your name in Hick's Place.

      CHARLESTON, S.C., Sep 1, 2011 (GlobeNewswire via COMTEX) -- Revolutions Medical Corporation (otcqb:RMCP) ("Revolutions Medical" or the "Company") is pleased to announce that today, the Company obtained an order from the South Carolina Ninth Judicial Circuit Court of Common Pleas, finding that Philip Maurice "Marty" Hicks ("Hicks") is liable for defaming the Company, its Chief Executive Officer, Ron Wheet, and its President, Tom O'Brien, by engaging in a cyber-smear campaign.

      According to the Company's complaint, Hicks, aka Tazmanian353 or Taz, made a series of false and defamatory statements about the Company and its employees on Yahoo! Finance and Raging Bull message boards between January 2006 and September 2010, including that Mr. Wheet "lied in official documents" and made unspecified "fraudulent misleading statements," and the Company itself was a mere "shell company" without any legitimate operations that had registered "no patents." The complaint alleged that these statements were false and defamatory because, among other things, the Company owns valuable patents (either granted or pending) for its auto retractable safety syringe and certain medical imaging technology. The Company's Chief Executive Officer, Ron Wheet, described the order as a "great victory for our shareholders."

      The order was entered as a sanction against Hicks based on his refusal to give deposition testimony, answer interrogatories, produce documents or otherwise comply with his discovery obligations in the litigation.

      The Company also wishes to comment on pervasive short selling of its stock. As previously noted by Buyins.Net, a provider of Regulation SHO compliance monitoring and short sale trading statistics, approximately 17.36 million shares of the Company's stock have been shorted since August 2009, and short selling has comprised approximately 36% of daily trading volume. Although Hicks' evasive tactics prevented the Company from obtaining evidence in the litigation against him, other information possessed by the Company leads it to suspect that Hicks' message postings may be part of a "short and distort" campaign intended to injure the Company and its shareholders and to generate profits for short sellers. The Company has compelling evidence that Hicks communicated with short sellers and his postings were then used to perpetuate false information to the investment community.

      Based on entry of the order, the Company intends both to pursue monetary damages and file complaints with the South Carolina Attorney General's Office and the U.S. Securities and Exchange Commission regarding possible violations of state and federal securities laws by Hicks and other short sellers.

3.08+0.02(+0.65%)12:55 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.